Compounds > lutetium
Page last updated: 2024-08-22

lutetium and biotin

lutetium has been researched along with biotin in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Axworthy, DB; Cutler, CS; Embree, MF; Jia, F; Jurisson, SS; Ketring, AR; Lewis, MR; Owen, NK; Schultz, J; Theodore, LJ; Zhang, J1
Mårtensson, L; Nilsson, R; Ohlsson, T; Senter, P; Sjögren, HO; Strand, SE; Tennvall, J; Wang, Z1
Axworthy, DB; Buchsbaum, DJ; Carpenter, M; Chaudhuri, TR; Khazaeli, MB; LoBuglio, AF; Schultz, J; Zinn, KR1

Other Studies

3 other study(ies) available for lutetium and biotin

ArticleYear
Biological comparison of 149Pm-, 166Ho-, and 177Lu-DOTA-biotin pretargeted by CC49 scFv-streptavidin fusion protein in xenograft-bearing nude mice.
    Nuclear medicine and biology, 2004, Volume: 31, Issue:2

    Topics: Animals; Antibodies, Neoplasm; Biotin; Cell Line, Tumor; Colonic Neoplasms; Drug Delivery Systems; Holmium; Humans; Immunoglobulin Fragments; Injections, Intravenous; Lutetium; Metabolic Clearance Rate; Mice; Mice, Nude; Organ Specificity; Organometallic Compounds; Promethium; Radioimmunotherapy; Radioisotopes; Radiopharmaceuticals; Recombinant Fusion Proteins; Streptavidin; Tissue Distribution

2004
Determining maximal tolerable dose of the monoclonal antibody BR96 labeled with 90Y or 177Lu in rats: establishment of a syngeneic tumor model to evaluate means to improve radioimmunotherapy.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2005, Oct-01, Volume: 11, Issue:19 Pt 2

    Topics: Animals; Antibodies, Monoclonal; Biotin; Body Weight; Brain; Chelating Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Heterocyclic Compounds, 1-Ring; Leukocytes; Lutetium; Maximum Tolerated Dose; Platelet Count; Radioimmunotherapy; Radioisotopes; Radionuclide Imaging; Radiopharmaceuticals; Rats; Time Factors; Yttrium Radioisotopes

2005
Intraperitoneal pretarget radioimmunotherapy with CC49 fusion protein.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2005, Nov-15, Volume: 11, Issue:22

    Topics: Animals; Antibodies, Monoclonal; Antibodies, Neoplasm; Antigens, Neoplasm; Biotin; Cell Line, Tumor; Colonic Neoplasms; Glycoproteins; Humans; Indium Radioisotopes; Injections, Intraperitoneal; Iodine Radioisotopes; Lutetium; Mice; Mice, Nude; Organometallic Compounds; Radioimmunotherapy; Radioisotopes; Streptavidin; Survival Analysis; Time Factors; Tissue Distribution; Treatment Outcome; Xenograft Model Antitumor Assays; Yttrium Radioisotopes

2005